Methocarbamol and Xhance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methocarbamol (methocarbamol) and Xhance (fluticasone propionate). Common drug interactions include urinary tract infection among females and thrombosis among males.

The phase IV clinical study analyzes what interactions people have when they take Methocarbamol and Xhance. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.

What is Xhance?

Xhance has active ingredients of fluticasone propionate. eHealthMe is studying from 2,012 Xhance users. Check the latest studies of Xhance.



On Jul, 15, 2026

21 people who take Methocarbamol and Xhance together, and have interactions are studied.

Methocarbamol and Xhance drug interactions.

What are the common drug interactions of Methocarbamol and Xhance, by gender? *:

female:

  1. Urinary tract infection
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Tooth abscess (pus formation in tooth)
  4. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  5. Fall
  6. Fungal infection
  7. Hand fracture
  8. Localised infection (infection at the single location)
  9. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  10. Seasonal allergy (allergic condition due to certain season)

male:

  1. Thrombosis (formation of a blood clot inside a blood vessel)
  2. Acute respiratory failure
  3. Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
  4. Pulmonary thrombosis (scarring in the lungs)
  5. Haematuria (presence of blood in urine)
  6. Keratoconus (a condition in which your eye's cornea is unable to hold its round shape)

What are the common drug interactions of Methocarbamol and Xhance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Accident
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Upper limb fracture
  4. Wrist fracture

60+:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Sinusitis (inflammation of sinus)
  4. Urinary tract infection
  5. Thrombosis (formation of a blood clot inside a blood vessel)
  6. Tooth abscess (pus formation in tooth)
  7. Tooth fracture
  8. Upper respiratory tract infection
  9. Infusion site discomfort
  10. Infusion site pain

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 16 people, 76.19%
  2. Urinary Tract Infection: 5 people, 23.81%
  3. High Blood Cholesterol: 2 people, 9.52%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Methocarbamol and Xhance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methocarbamol and Xhance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xhance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methocarbamol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xhance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol and fluticasone propionate (the active ingredients of Methocarbamol and Xhance, respectively), and Methocarbamol and Xhance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: